Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritis

Detalles Bibliográficos
Autores principales: Fleischmann, Roy, Alam, Jahangir, Arora, Vipin, Bradley, John, Schlichting, Douglas E, Muram, David, Smolen, Josef S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640108/
https://www.ncbi.nlm.nih.gov/pubmed/29071120
http://dx.doi.org/10.1136/rmdopen-2017-000546
_version_ 1783270992336912384
author Fleischmann, Roy
Alam, Jahangir
Arora, Vipin
Bradley, John
Schlichting, Douglas E
Muram, David
Smolen, Josef S
author_facet Fleischmann, Roy
Alam, Jahangir
Arora, Vipin
Bradley, John
Schlichting, Douglas E
Muram, David
Smolen, Josef S
author_sort Fleischmann, Roy
collection PubMed
description
format Online
Article
Text
id pubmed-5640108
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-56401082017-10-25 Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritis Fleischmann, Roy Alam, Jahangir Arora, Vipin Bradley, John Schlichting, Douglas E Muram, David Smolen, Josef S RMD Open Rheumatoid Arthritis BMJ Publishing Group 2017-10-10 /pmc/articles/PMC5640108/ /pubmed/29071120 http://dx.doi.org/10.1136/rmdopen-2017-000546 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Rheumatoid Arthritis
Fleischmann, Roy
Alam, Jahangir
Arora, Vipin
Bradley, John
Schlichting, Douglas E
Muram, David
Smolen, Josef S
Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritis
title Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritis
title_full Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritis
title_fullStr Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritis
title_full_unstemmed Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritis
title_short Safety and efficacy of baricitinib in elderly patients with rheumatoid arthritis
title_sort safety and efficacy of baricitinib in elderly patients with rheumatoid arthritis
topic Rheumatoid Arthritis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640108/
https://www.ncbi.nlm.nih.gov/pubmed/29071120
http://dx.doi.org/10.1136/rmdopen-2017-000546
work_keys_str_mv AT fleischmannroy safetyandefficacyofbaricitinibinelderlypatientswithrheumatoidarthritis
AT alamjahangir safetyandefficacyofbaricitinibinelderlypatientswithrheumatoidarthritis
AT aroravipin safetyandefficacyofbaricitinibinelderlypatientswithrheumatoidarthritis
AT bradleyjohn safetyandefficacyofbaricitinibinelderlypatientswithrheumatoidarthritis
AT schlichtingdouglase safetyandefficacyofbaricitinibinelderlypatientswithrheumatoidarthritis
AT muramdavid safetyandefficacyofbaricitinibinelderlypatientswithrheumatoidarthritis
AT smolenjosefs safetyandefficacyofbaricitinibinelderlypatientswithrheumatoidarthritis

Ejemplares similares